Risks stratification and benefits of PCI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
'''Editor(s)-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond) | '''Editor(s)-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond) | ||
Revision as of 13:31, 29 October 2012
Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond)